+254745601747

info@clinicalmedhub.com

Nairobi, Kenya

Alprazolam - Drug Details

Alprazolam (Xanax)

Classification
Benzodiazepine
Mechanism of Action
Indications
Anxiety disorders, panic disorder
Dosage and Administration
0.25-0.5 mg orally three times daily
Forms
Tablets, extended-release tablets
Side Effects
Drowsiness, dizziness, dry mouth
Contraindications
Severe respiratory insufficiency, acute narrow-angle glaucoma
Interactions
Caution with other CNS depressants
Precautions
Use caution in patients with a history of substance abuse
Pharmacokinetics
Half-life: 11.2 hours, metabolized in the liver
Pharmacodynamics
Enhances GABAergic neurotransmission
Storage Requirements
Store at room temperature, protect from light
Patient Counselling
Avoid alcohol, may cause sedation and impair ability to drive or operate machinery
Back to List
ClinicalMedHub - Modern Footer

ClinicalMedHub

Comprehensive medical resources, research tools, and professional networking for healthcare providers and patients worldwide.

Scroll down to see the modern footer design